Clinical Trials
2 trialsNCT04501094 2022-03-22
A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00001378 2008-03-04
A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed